The objective of this study was to investigate differences in electrocardiographic (ECG) parameters and the prevalence of left ventricular hypertrophy (LVH) by various ECG criteria between different ethnic groups in west Birmingham, United Kingdom. In all, 380 consecutive patients, mean age 63 (7.8) years, 75 (20%) female patients assessed for inclusion in hypertension trials in a city centre teaching hospital were studied: 303 (80%) were Caucasian, 43 (11.4%) Afro-Caribbean and 32 (8.5%) South Asian. LVH was assessed using seven different criteria, with adjustment for age and body mass index (BMI). The performance of the various criteria were compared between the three ethnic groups. There were significant differences in the R-wave voltage in lead aVL, the Sokolow-Lyon voltage and in criteria based on limb lead voltages alone between the three ethnic groups. Highest ECG voltages were seen in AfroCaribbeans, and this translated into a significantly higher prevalence of LVH when assessed by the R-wave in aVL and the Sokolow-Lyon criteria. There were no significant differences between Caucasians and South Asians. These differences were abolished after adjustment for age and BMI. There was no difference in the Cornell voltage or its derivatives in men between the three ethnic groups. In conclusion, apparent differences in electrocardiographic voltage and the prevalence of LVH between ethnic groups are dependent upon the criteria chosen and may simply be secondary to differences in BMI. Unlike Afro-Caribbean patients, South Asians do not demonstrate significant differences in ECG voltage compared with Caucasians.
Introduction
Although the detection of left ventricular hypertrophy (LVH) by electrocardeography (ECG) is an insensitive technique, its presence is an important marker for a poor prognosis. For a given level of blood pressure, LVH conveys a 3-4 fold increase in sudden death, myocardial infarction, cardiac failure and stroke. 1, 2 The increased mortality with LVH can even be graded according to increasing voltage on the ECG from within the normal range, and furthermore, changes in ECG voltage over time carry prognostic significance. 3, 4 The outlook is even worse if there are repolarisation abnormalities in the lateral chest leads (the strain pattern). Different methods of detecting LVH using the ECG have varying sensitivities and specificities and all are affected by obesity and age. 5 The performance of the ECG may be improved by adjusting for both age and obesity as assessed by measuring body mass index (BMI). Formulae based on the Framingham Study population have been published for this purpose. 6 There are some data that hypertensives of African origin, both in the United States 7 and the United Kingdom 8 have a higher prevalence of LVH by both ECG and (in most, but not all studies) echocardiography than Caucasian subjects. Little data, however, exist on South Asian hypertensives in the United Kingdom, who are an ethnic group with a high incidence of ischaemic heart disease.
We hypothesised that, while the prevalence of ECG-LVH in Afro-Caribbean patients might be higher than in white patients, this difference would be abolished after adjustment for age and BMI. There were almost no data on LVH in South Asian hypertensive patients who have a lower stroke but higher coronary heart disease risk than Afro-Caribbeans. 9 To test this hypothesis, we investigated ECG criteria for LVH in consecutive hypertensive patients from the three main ethnic groups being assessed in our unit.
Patients and methods
We performed a cross-sectional study of 380 consecutive hypertensive patients screened for inclusion into a number of hypertension trials at our city centre teaching hospital. This hospital serves a population catchment of 350 000, with 64% being white Caucasian, 11% Afro-Caribbean and 25% South Asian. The latter group is almost exclusively (490%) of Punjabi origin, with a small minority of Bengali origin. Patients in the present study were included if they were untreated (4160/95 mmHg), or if treated, had uncontrolled blood pressure (4140/90 mmHg).
The blood pressure was measured after 10 min rest in a quiet room with an Omron HEM 705-CP; the latter device fulfils the criteria of the British Hypertension Society (BHS) and American Association for the Advancement of Medical Instrumentation (AAMI) protocols. 10 Three consecutive blood pressure readings were taken and the average of the last two readings was used in our analyses.
Standard 12-lead electrocardiograms were performed using a Marquette Cardiosmart ECG machine (Marquette Hellige GmbH, Freiburg, Germany) by specially trained nurses or doctors using conventional techniques. Particular attention was given to the correct and consistent positioning of the chest leads. We excluded patients with bundle branch block, Wolf Parkinson White syndrome, ongoing angina, or previous myocardial infarction and secondary or malignant hypertension.
All ECG voltages were measured manually to the nearest 0.5 mm, and entered into a computerised database. The following indices of ECG-LVH were recorded: R-wave voltage in lead aVL (R aVL), the Sokolow-Lyon criteria (S in V1 þ R in V5 or V6), the Cornell voltage, cornell voltage duration product, the Cornell/QRS II criteria, and the Lewis criteria (Table 1) .
Adjustments were made for age and BMI (wt/ht 2 ; kg/m 2 ) using the published formulae of Norman and Levy. 6 Patients were divided into self-defined racial groups and those other than Caucasian, AfroCaribbean and South Asian were excluded from analysis.
Statistical methods
Categorical data are compared by the w 2 -test. Blood pressures and lipid parameters are expressed as mean (s.d.), and compared using one-way ANOVA and Tukey's post hoc test for within group comparisons. The majority of ECG voltages and Framingham risk scores were non-normally distributed and were expressed as median (interquartile range, IQR) and compared using the Kruskal-Wallis test for comparisons between the three ethnic groups and Tukey's post hoc test (after log transformation) for within-group comparisons. Stepwise multiple regression analyses were carried out using the various ECG parameters as dependent variables and relevant clinical indices including both systolic and diastolic blood pressure, age, BMI, and ethnic group as predictors. All analyses were carried out using the SPSS version 10 software (SPSS Inc., Chicago, IL, USA).
Results
We studied 380 patients (305 males; mean age of 63.0 (s.d.7.8) years): their average blood pressure was 165/90 mmHg (s.d.17/10), 71(19%) were smokers and 91(24%) had Type II diabetes mellitus. Of the total cohort, 303(80%) were Caucasian, 43(11.4%) Afro-Caribbean and 32(8.5%) South Asian ( Table 2) . Two Chinese patients were excluded from the analysis, which was conducted in 378 patients.
South Asians tended to be slightly younger, while the prevalence of diabetes mellitus was highest in Afro-Caribbeans, intermediate in Indo-Asians and lowest in Caucasians (Po0.0001). The latter group had the mean highest serum cholesterol levels (Po0.0001). South Asian patients, by virtue of their age, had the lowest calculated 10-year coronary heart disease risk (P ¼ 0.02). There were no significant differences in blood pressure, gender mix or BMI between the ethnic groups ( Table 2) . 
Variation in ECG measurements by ethnic groups
In men, there were significant differences in the ECG voltage between the three groups for the SokolowLyon voltage (P ¼ 0.013). and ECG criteria based on the limb leads alone. There were no significant differences in the Cornell voltage or its derivatives (Table 3) . When the ECG voltages were corrected for age and BMI according to the formulae of Norman and Levy, 6 racial differences in voltage were no longer apparent (Table 3a) . Using Tukey's post hoc analysis, differences in the Sokolow-Lyon voltage (P ¼ 0.004) and RI þ SIII (P ¼ 0.013) criteria were due to increased voltages in Afro-Caribbean patients.
There were no significant differences in ECG voltage between South Asian and Caucasian Ethnic differences in LV size and ECG criteria CGC Spencer et al patients. Data for women are presented in Table 4a , the numbers of Afro-Caribbean and South Asian patients were very small, and thus none of the differences between the groups reaching statistical significance care must, therefore, be taken in interpreting these data.
Variation in the prevalence of LVH by ethnic group
In men, there were significant differences in the prevalence of LVH between the three groups when assessed by the height of the R-wave in lead aVL (P ¼ 0.04) and by the Sokolow-Lyon voltage (P ¼ 0.039) but not by the other criteria. These differences were due to a significantly higher prevalence of LVH among Afro-Caribbean patients compared to Caucasians (w 2 -test, P ¼ 0.009 for Sokolow-Lyon and P ¼ 0.011 for RaVL) (Table 3b ). There were no significant differences in the prevalence of LVH using the age-and BMI-adjusted criteria (Table 3b) .
In women, the results need to be treated with caution due to small numbers; however, there was a significantly higher prevalence of LVH using the Cornell voltage criteria in Afro-Caribbean patients (w 2 -test, P ¼ 0.013), but there were no significant differences using the other criteria (Table 4b ).
Multivariate analysis
In the stepwise linear regression analysis, taking into account, gender, age, BMI, systolic and diastolic blood pressure, ethnic group, and smoking status, Afro-Caribbean ethnic origin emerged as the most significant predictor of Sokolow- 
Discussion
In this study, we have demonstrated that there are no significant differences in ECG voltage between hypertensive South Asian and Caucasian patients, despite similar mean blood pressures in each of the ethnic groups. As with many previous studies, we have found greater ECG voltages in Afro-Caribbean hypertensives, when compared to white Caucasian Values are n (%). *Po0.05 vs Caucasians.Adj. ¼ adjusted for age and BMI according to the formulae of Norman and Levy (1995) .
Ethnic differences in LV size and ECG criteria CGC Spencer et al patients. There were, however, differences in the performance of the various ECG criteria with large racial variation in the Sokolow-Lyon voltage and in criteria using limb leads alone. In contrast, the Cornell voltage and its derivatives, the Cornell/total QRS voltage in lead II and the Cornell voltage duration product did not vary between racial groups. This would be consistent with the greater sensitivity and specificity of the Cornell voltage and in particular, the Cornell voltage duration product which with a specificity 96% and sensitivity of 50% outperforms other ECG criteria for LVH. 1 Furthermore, adjustment for age and BMI using the formulae of Norman and Levy rendered differences between races nonsignificant, although this adjustment of ECG-LVH criteria for body mass index was to reduce the relationship to one primarily of LV mass to BMI, and not the ECG-LVH criteria, with BMI being a strong predictor of LV mass in its own right in the Framingham study. This undue emphasis on this adjustment may be problematic given the strong inverse correlation of Sokolow-Lyon voltage and its constituent R-and S-wave amplitudes with BMI as opposed to the much weaker relationship of Cornell voltage to obesity. Furthermore, we accept that this adjustment was made in the predominantly Caucasian Framingham cohort, rather than in a multiethnic one.
When translated into differences in prevalence of LVH significant intergroup variations were found only for the Sokolow-Lyon voltage and the magnitude of the R-wave in lead aVL. This is likely to be due to the relatively small numbers of patients who actually had LVH with much of the significant intergroup variation in voltage taking place within the normal range. Had there been a greater prevalence of LVH in our population or had we set a lower threshold voltage to define LVH differences, the other criteria might have become apparent.
Although in many clinical settings, the greater sensitivity and specificity of echocardiography has rendered the detection of LVH by ECG of secondary importance, the ECG is still widely used as a screening tool and in both clinical and epidemic logical studies. For example, the Losartan Intervention For Endpoint reduction (LIFE) in hypertension study has used ECG criteria for both recruitment of patients and to assess regression of LVH. Like our study, the LIFE investigators found a higher proportion of black patients in those identified as having LVH by the Sokolow-Lyon criteria compared with the Cornell voltage duration product. 11 Our data suggest that there are no significant differences in the prevalence of ECG-LVH in British South Asians when compared with Caucasians. Furthermore, differences between races may be minimised by choosing the Cornell criteria or its derivatives and using published formulae to correct for age and BMI.
This study has several important limitations. Firstly, we have no echocardiographic data on our patients and so we are unable to tell whether the differences in ECG voltage we have found are artefacts of race or in fact, reflect true differences in the prevalence of LVH by race. The lack of echocardiographic data also prevents us from assessing the sensitivity and specificity of the various criteria in our populations. Secondly, both the cardiovascular risk estimates and the adjustment criteria for the ECGs used were developed in the Framingham study, where the racial demographics of the population are different, and thus their application to Afro-Caribbean and South Asian populations has not been validated. Both treated and untreated patients were studied, and we accept that drug treatment may influence the degree of LVH-we have minimised this by including treated patients only if they had uncontrolled blood pressure (4140/90 mmHg). Finally, we acknowledge that some differences in cardiovascular risk factors may exist between subgroups from the South Asian community, 12 but our catchment population is almost exclusively Punjabi in origin.
In conclusion, apparent differences in electrocardiographic LVH between ethnic groups are dependent upon the criteria chosen and may simply be secondary to differences in BMI. Unlike AfroCaribbean patients. South Asian subjects do not demonstrate significant differences in ECG voltage compared with Caucasians.
